Development of gemcitabine-modified miR-15a as a novel, multimodal treatment strategy to overcome 5-FU and oxaliplatin resistance in colorectal cancer
Anushka Ojha, A.S. Pal, Max Chao, Ramana V. Davuluri, Jingfang Ju
This paper develops Gem-miR-15a, a gemcitabine-modified microRNA, which overcomes 5-FU and oxaliplatin resistance in colorectal cancer with high potency and low toxicity.
Journal of Experimental & Clinical Cancer Research · Oct 27, 2026Peer-reviewedCancer Biology